Biogen Int'l GmbH v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2021) | McDonnell Boehnen Hulbert & Berghoff LLP
As is well-known, Congress established the Federal Circuit as a circuit court of appeals to harmonize U.S. patent law in an environment where regional Circuit Courts had developed their...
Source: jdsupra.com